Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 2.9B | 2.9B | 2.7B | 2.8B |
| Cost of revenue | 1.4B | 1.5B | 1.4B | 1.4B |
| Gross profit | 1.4B | 1.4B | 1.3B | 1.3B |
| Operating expense | ||||
| Research & development | 69M | 59M | 55M | 61M |
| Selling general and admin | 273M | 303M | 293M | 268M |
| Other operating expenses | 73M | 75M | 68M | 69M |
| Operating income | 620M | 603M | 519M | 610M |
| Non operating interest income | ||||
| Income | 42M | 57M | 67M | 80M |
| Expense | 174M | 180M | 179M | 186M |
| Other income expense | -17M | -19M | -4M | -8M |
| Pretax income | 471M | 461M | 403M | 496M |
| Tax provision | 63M | 69M | 50M | 72M |
| Net income | 408M | 392M | 353M | 424M |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | 1.0B | 1.0B | 936M | 1.0B |
| Net income from continuing op. | 408M | 392M | 353M | 424M |
| Minority interests | -56M | -68M | -78M | -71M |
| Preferred stock dividends | — | — | — | — |